Selection of patients with pancreatic adenocarcinoma who may benefit from radiotherapy
Despite combination chemotherapy demonstrating a positive effect on survival, the clinical outcomes of pancreatic adenocarcinoma (PDAC) remain poor. Radiotherapy was previously a component of the curative trea...
Source: Radiation Oncology - Category: Cancer & Oncology Authors: I-Shiow Jan and Hui Ju Ch ’ang Tags: Review Source Type: research